Navigation Links
Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No

The FDA has given its consent for the novel version of the allergy medicine, Clarinex-D 12 Hour, to alleviate nasal, non nasal symptoms and nasal congestion occurring in adults and children above the age of 12. According to the // researchers, this medicine will be in time for the spring allergy season.

It is estimated that about 36 million people in the U.S. are troubled by seasonal allergies with apparent runny nose, sneezing, nasal congestion, and itchy, watery eyes, symptoms.

Clarinex (desloratadine) , used for treatment of seasonal allergy symptoms, is a nonsedating antihistamine procured only by prescription . Approval for Clarinex-D 24 Hour (containing 5 milligrams desloratadine and 240 milligrams pseudo ephedrine), prescribed only once a day was obtained last spring. Clarinex-D 12 hour, the recently approved medicine contains 2.5 milligrams desloratadine and 120 milligrams pseudo ephedrine, and can be consumed twice a day.

The FDA approval was close on the heels of two clinical trials involving 1,200 people or more who suffered seasonal allergies. The trails involved comparison of the treatment with Clarinex-D 12 HOUR extended-release tablets with pseudoephedrine alone and desloratadine alone. The results depicted that the extended-release-combined medication eased nasal congestion as well as provided immense relief compared to desloratadine alone, relieving other allergy symptoms better than pseudoephedrine alone.

Insomnia, headache, dry mouth, and fatigue are some of the common side effects associated with Clarinex-D 12 Hour use. This medicine should not be taken by those suffering from narrow-angle glaucoma, severe high blood pressure or heart disease, urination difficulty, or by patients who may have taken a monoamine-oxidase inhibitor 14 days prior to the use of this drug. It also recommended that those with certain other medical conditions such as high blood pressure, diabetes, heart disease, thyroid, liver , or kidney problems, or enlarged prostate should seek the advice of a medical specialist before resorting to the use of Clarinex-D 12 hour or Clarinex-D 24 Hour.


'"/>




Related medicine news :

1. British Doctor cleared of murder
2. Mist over a way to help premature babies breathes cleared!
3. Business model for Liver Institute cleared by Delhi Cabinet
4. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
5. Gene Therapy Gives Hope For Patients With Muscular Dystrophy
6. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
7. US Doctors Association Gives away $110,000 To NGO’
8. Woman In Coma Gives Birth To Daughter
9. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant
10. New Eye Surgery Gives Hope To Short-Sighted
11. Jharkhand Gives Health industry status
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... i2i Population Health, ... in KLAS category winner, has named Daniel P. Bullington as chief technology officer. ... technology platform and product offerings,” says Justin Neece, president. “Daniel is an excellent ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... By ... season underway in Sonoma County. While officials call for diligence, asking homeowners to scout ... looking at potential health concerns. Along with the annoying buzz of mosquitos is the ...
(Date:5/23/2017)... ... ... New patients from Charleston, SC, are now welcome to receive a full ... with or without a referral. A full mouth reconstruction can transform the appearance of ... Charleston, SC. Those who suffer from gum disease, misaligned teeth or jaw pain can ...
(Date:5/23/2017)... ... May 23, 2017 , ... Therachat , a smart ... in an infographic on the current state of anxiety in support of National Mental ... was conducted in April 2017 and benchmarked general anxiety levels as well as identified ...
(Date:5/22/2017)... ... May 22, 2017 , ... Dr. Kiya Green, ... with periodontal plastic surgery treatments, including crown lengthening and gum reduction ... these esthetic and functional procedures to help patients improve their oral health, reduce ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... -- Amy Baxter MD, chief executive officer and founder of ... was awarded a 2017 Top 40 Healthcare Transformer designation ... the MM&M Top 40 Healthcare Transformers dinner and awards ... May 10, 2017. The dinner followed a full-day conference ... pill."  "Innovation goes beyond invention," noted Baxter ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) announced today ... ended April 1, 2017 .   GAAP diluted earnings ... the prior year period as the sale of the ... non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue of ... terms.  Excluding the effects of blood screening and the ...
(Date:5/10/2017)... CSSi, the global leader in patient recruitment, ... is proud to announce the launch of its newly ... both enriched content and a customized layout that provides ... already well-established position as the top global patient recruitment ... months of hard work, we are delighted to officially ...
Breaking Medicine Technology: